학술논문

Preclinical Evidence for Targeting PI3K/mTOR Signaling with Dual-Inhibitors as a Therapeutic Strategy against Cutaneous T-Cell Lymphoma
Document Type
Article
Source
In: Journal of Investigative Dermatology. (Journal of Investigative Dermatology, May 2020, 140(5):1045-1053.e6)
Subject
Language
English
ISSN
15231747
0022202X